SEC Form 4 · accession 0001127602-17-008825

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Corporate Executive VP

Period of report

Feb 24, 2017

Accepted (ET)

Feb 28, 2017 · 8:39 am EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001100682

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Feb 24, 2017	A	7,246	$0.00	A	44,594	D
Common Stock	Feb 26, 2017	F	803	$88.05	D	43,791	D
Common Stock	holding	—	—		—	30,493	I	By Revocable Trust

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Options (Right to Buy)^F2	$88.05	Feb 24, 2017	A	34,922	A	Feb 24, 2018	Feb 24, 2022	Common Stock	34,922	34,922	D

F1Consists of 7,246 unvested restricted stock units that vest as follows: 1,811 shares vest one (1) year from the date of issuance, 1,812 shares vest two (2) years from the date of issuance, 1,811 shares vest three (3) years from the date of issuance, and 1,812 shares vest four (4) years from the date of issuance.
F2Stock options vest as follows: 8,730 options vest one (1) year from the date of grant, 8,731 options vest two (2) years from the date of grant, 8,730 options vest three (3) years from the date of grant, and 8,731 options vest four (4) years from the date of grant.